We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$121M
2
ONC
BeOne Medicines Ltd
ONC
+$66.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$56.6M
4
WELL icon
Welltower
WELL
+$48.8M
5
CRDO icon
Credo Technology Group
CRDO
+$45.3M

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
426
DELISTED
Hess
HES
$2.82M 0.02%
17,629
-1,911
-10% -$281K
KURA icon
427
Kura Oncology
KURA
$826M
$2.79M 0.02%
422,652
– –
NLY icon
428
Annaly Capital Management
NLY
$17.4B
$2.77M 0.02%
136,440
+294
+0.2% +$6.05K
CPRT icon
429
Copart
CPRT
$27.4B
$2.75M 0.02%
48,538
-6,071
-11% -$342K
HBAN icon
430
Huntington Bancshares
HBAN
$34.5B
$2.71M 0.02%
180,320
-26,848
-13% -$433K
CELC icon
431
Celcuity
CELC
$4.27B
$2.66M 0.02%
263,590
– –
CAG icon
432
Conagra Brands
CAG
$7.19B
$2.66M 0.02%
99,688
-3,050
-3% -$78.7K
DAR icon
433
Darling Ingredients
DAR
$9.69B
$2.63M 0.02%
84,303
-8,374
-9% -$293K
ERII icon
434
Energy Recovery
ERII
$435M
$2.59M 0.02%
162,976
– –
FOXA icon
435
Fox Class A
FOXA
$24.7B
$2.52M 0.02%
44,607
+7,639
+21% +$404K
DHI icon
436
D.R. Horton
DHI
$40.7B
$2.5M 0.02%
19,691
-5,390
-21% -$723K
ODFL icon
437
Old Dominion Freight Line
ODFL
$44.2B
$2.5M 0.02%
15,106
-1,323
-8% -$241K
FANG icon
438
Diamondback Energy
FANG
$56.2B
$2.49M 0.02%
15,561
-5,479
-26% -$884K
AME icon
439
Ametek
AME
$55B
$2.46M 0.02%
14,295
-2,475
-15% -$450K
TEAM icon
440
Atlassian
TEAM
$24.9B
$2.44M 0.02%
11,496
-244
-2% -$64.4K
ENIC icon
441
Enel Chile
ENIC
$6.29B
$2.44M 0.02%
+745,000
New +$2.39M
EFX icon
442
Equifax
EFX
$20.7B
$2.43M 0.02%
9,983
-1,487
-13% -$374K
VRT icon
443
Vertiv
VRT
$87.6B
$2.42M 0.02%
33,586
-193,991
-85% -$20.6M
PRAX icon
444
Praxis Precision Medicines
PRAX
$8.58B
$2.41M 0.02%
63,671
-54,299
-46% -$3.39M
GEHC icon
445
GE HealthCare
GEHC
$31.6B
$2.41M 0.02%
29,848
-929
-3% -$79.8K
RJF icon
446
Raymond James Financial
RJF
$33.6B
$2.39M 0.02%
17,202
-3,608
-17% -$560K
NTRS icon
447
Northern Trust
NTRS
$22.4B
$2.38M 0.01%
24,110
-3,580
-13% -$380K
TROW icon
448
T. Rowe Price
TROW
$25.6B
$2.36M 0.01%
25,695
-3,691
-13% -$390K
WBD icon
449
Warner Bros
WBD
$63.9B
$2.32M 0.01%
216,682
-1,161
-0.5% -$12.1K
HSAI
450
Hesai Group
HSAI
$2.6B
$2.32M 0.01%
+157,000
New +$2.68M
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.